Directory

>

Nathan Sanburn

avatar

Nathan Sanburn

Chief Business Officer | Verastem Oncology

Indianapolis, Indiana, United States

View contact details (it's free)

Nathan Sanburn

Summary

Nathan Sanburn is a seasoned executive in the biopharmaceutical sector, currently serving as Chief Business Officer at Verastem Oncology. With a robust background in oncology strategy and development, he has played pivotal roles in various leadership positions at Eli Lilly, where he drove business development and strategic collaborations within the Oncology Business Unit. Nathan's expertise spans a range of areas, including clinical research, drug development, and commercialization. He is known for his ability to forge partnerships across the pharmaceutical landscape and has successfully led initiatives that align R&D strategies with market needs. His academic foundation in biology from Purdue University and Indiana University has equipped him with a strong scientific acumen that complements his business insights. Nathan is passionate about advancing cancer therapies and is committed to improving patient outcomes through innovative strategies and collaborations.

General

Specialist

Technical Background

Leadership Experience

Moderate Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Nathan Sanburn

Work Experience

company logo

Chief Business Officer at

Verastem Oncology

August 2024 - Present

company logo

Senior Vice President- Corporate Development and External Engagement at

Verastem Oncology

April 2023 - August 2024

company logo

Vice President- Head of Business Development at

Verastem Oncology

February 2022 - April 2023

company logo

Sr Advisor Global Business Development and Strategic Collaborations- Oncology Business Unit at

Eli Lilly and Company

February 2018 - February 2022

company logo

Regional Director- East US Medical Affairs Oncology at

Eli Lilly and Company

October 2015 - February 2018

company logo

Director- Strategy and Business Development - Oncology at

Eli Lilly and Company

October 2013 - October 2015

company logo

Oncology Strategy and Transformation- Investigator Engagement at

Eli Lilly and Company

July 2011 - October 2013

company logo

Oncology Program Team Leader- Phase1/2 Cell Cycle Inhibitor program at

Eli Lilly and Company

January 2011 - June 2011

šŸ’¼

Oncology- Director Scientific Search and Evaluation at

Eli Lilly

January 2005 - January 2011

šŸ’¼

Clinical Pharmacokinetics-Operations at

Eli Lilly

April 2000 - January 2005

company logo

Research Scientist at

Indiana University School Of Medicine

January 1995 - January 2000

Logos provided by Logo.dev

Nathan Sanburn

Education

Purdue University, Ms

January 1994 - January 1995

Indiana University Bloomington, Bachelor's Degree

January 1990 - January 1994

Frequently Asked Questions about Nathan Sanburn

What is Nathan Sanburn email address?

Nathan Sanburn's primary email address is *******@lilly.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Nathan Sanburn work for?

Nathan Sanburn is a Chief Business Officer at Verastem Oncology, a company specializing in Commercial physical research.

Where Nathan Sanburn graduated from?

Nathan Sanburn holds a degree in Biology from Purdue University.

How can I directly contact Nathan Sanburn?

To contact Nathan Sanburn directly, you can use the email address *******@lilly.com. Complete contact information is available upon registration with Muraena.

Who is Nathan Sanburn?

Nathan Sanburn is a seasoned executive in the biopharmaceutical sector, currently serving as Chief Business Officer at Verastem Oncology. With a robust background in oncology strategy and development, he has played pivotal roles in various leadership positions at Eli Lilly, where he drove business development and strategic collaborations within the Oncology Business Unit. Nathan's expertise spans a range of areas, including clinical research, drug development, and commercialization. He is known for his ability to forge partnerships across the pharmaceutical landscape and has successfully led initiatives that align R&D strategies with market needs. His academic foundation in biology from Purdue University and Indiana University has equipped him with a strong scientific acumen that complements his business insights. Nathan is passionate about advancing cancer therapies and is committed to improving patient outcomes through innovative strategies and collaborations.

Nathan`s contact details

mail

*******@lilly.com

********@verastem.com

Colleagues

avatar
Faye Seyedi

Vice President, CMC

avatar
Stephen Jamieson

Chief Information Officer

Robert Pintar

Senior Vice President, Technical Operations

avatar
Dan Calkins

Chief Financial Officer

avatar
Dan Paterson

President and CEO

avatar
Elizabeth Noble

Vice President and Head of Clinical Operations

Leigh Hartnagel

Vice President and Head of Marketing

avatar
Jonathan Pachter

Chief Scientific Officer

avatar
Cathy Carew

Chief Organization Effectiveness Officer

View Contact details (it's free)
Request Profile Removal